» Articles » PMID: 21314806

Lymphangioleiomyomatosis Suspected to Be a Gynecologic Disease

Overview
Date 2011 Feb 15
PMID 21314806
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Lymphangioleiomyomatosis (LAM) is a rare, systemic disorder that predominantly affects women. Although patients with LAM mostly present with pulmonary symptoms, some patients may present initially with extrapulmonary symptoms. We present a case of a 30-year-old Japanese female with abdominal pain during menstrual periods was suspected of having ovarian cancer due to exaggerated ascites observed at a local clinic. Subsequently, she was transferred to our hospital for further investigations, and was diagnosed with LAM. Three years after diagnosis, she had a girl by cesarean section to avoid the progression of pulmonary LAM by vaginal delivery. The patient is undergoing follow-up treatment with the administration of gonadotropin-releasing hormone-analog. Though LAM is rare, gynecologists should know about it because it may occur with gynecological symptoms in young women.

Citing Articles

Complications of lymphangioleiomyomatosis in pregnancy: a case report and review of the literature.

Wang-Koehler E, Kern-Goldberger A, Srinivas S AJOG Glob Rep. 2024; 4(1):100309.

PMID: 38327672 PMC: 10848140. DOI: 10.1016/j.xagr.2024.100309.


Systematic Review of Lymphangioleiomyomatosis Outcomes in Pregnancy and a Proposed Management Guideline.

Champion M, Maier J, Bushman E, Barney J, Casey B, Sinkey R Am J Perinatol. 2023; 41(S 01):e1508-e1520.

PMID: 36898409 PMC: 10582203. DOI: 10.1055/a-2051-8395.


Extrapulmonary uterine lymphangioleiomyomatosis (LAM) and dysfunctional uterine bleeding: the first presentation of LAM in a tuberous sclerosis complex patient.

Grant L, Chipwete S, Soo Hoo S, Bhatnagar A BMJ Case Rep. 2019; 12(2).

PMID: 30804158 PMC: 6388898. DOI: 10.1136/bcr-2018-226358.


A case of lymphangioleiomyomatosis associated with endometrial cancer and severe systemic lupus erythematosus.

Suzuki K, Nagasaka K, Oda K, Abe H, Maeda D, Matsumoto Y BMC Cancer. 2016; 16:390.

PMID: 27377753 PMC: 4932736. DOI: 10.1186/s12885-016-2413-z.